Sam McCrabb1, Amanda L Baker, John Attia, Zsolt J Balogh, Natalie Lott, Kerrin Palazzi, Justine Naylor, Ian A Harris, Christopher M Doran, Johnson George, Luke Wolfenden, Eliza Skelton, Billie Bonevski. 1. *School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, Callaghan, New South Wales, Australia; †Hunter Medical Research Institute, University of Newcastle, New Lambton, New South Wales, Australia; Departments of ‡General Medicine, and §Traumatology, John Hunter Hospital, New Lambton, New South Wales, Australia; ‖Whitlam Orthopaedic Research Centre, Ingham Institute for Applied Medical Research, Liverpool Hospital, Liverpool, New South Wales, Australia; ¶South Western Sydney Clinical School, Faculty of Medicine, University of New South Wales, Liverpool, New South Wales, Australia; **School of Human, Health and Social Sciences, Central Queensland University, Brisbane, Queensland, Australia; ††Centre for Medicine Use and Safety, Monash University, Parkville, Victoria, Australia; and ‡‡Hunter New England Population Health, Wallsend, New South Wales, Australia.
Abstract
OBJECTIVE: This study investigates orthopaedic trauma patients smoking cessation history, intentions to quit, receipt of smoking cessation care during hospital admission, and patient-related factors associated with receipt of smoking cessation care. METHODS: An online cross-sectional survey of orthopaedic trauma patients was conducted in 2 public hospitals in New South Wales, Australia. Prevalence of smoking and associated variables were described. Logistic regressions were used to examine whether patient characteristics were associated with receipt of smoking cessation care. RESULTS: Eight hundred nineteen patients (response rate 73%) participated. More than 1 in 5 patients (21.8%) were current smokers (n = 175). Of the current smokers, more than half (55.3%) indicated making a quit attempt in the last 12 months and the majority (77.6%) were interested in quitting. More than a third of smokers (37.4%) were not advised to quit; 44.3% did not receive any form of nicotine replacement therapy; and 24.1% reported that they did not receive any of these 3 forms of smoking cessation care during their admission. Provision of care was not related to patient characteristics. CONCLUSIONS: The prevalence of smoking among the sample was high. Respondents were interested in quitting; however, the provision of care during admission was low. Smoking cessation interventions need to be developed to increase the provision of care and to promote quit attempts in this Australian population. LEVEL OF EVIDENCE: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.
OBJECTIVE: This study investigates orthopaedic traumapatients smoking cessation history, intentions to quit, receipt of smoking cessation care during hospital admission, and patient-related factors associated with receipt of smoking cessation care. METHODS: An online cross-sectional survey of orthopaedic traumapatients was conducted in 2 public hospitals in New South Wales, Australia. Prevalence of smoking and associated variables were described. Logistic regressions were used to examine whether patient characteristics were associated with receipt of smoking cessation care. RESULTS: Eight hundred nineteen patients (response rate 73%) participated. More than 1 in 5 patients (21.8%) were current smokers (n = 175). Of the current smokers, more than half (55.3%) indicated making a quit attempt in the last 12 months and the majority (77.6%) were interested in quitting. More than a third of smokers (37.4%) were not advised to quit; 44.3% did not receive any form of nicotine replacement therapy; and 24.1% reported that they did not receive any of these 3 forms of smoking cessation care during their admission. Provision of care was not related to patient characteristics. CONCLUSIONS: The prevalence of smoking among the sample was high. Respondents were interested in quitting; however, the provision of care during admission was low. Smoking cessation interventions need to be developed to increase the provision of care and to promote quit attempts in this Australian population. LEVEL OF EVIDENCE: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.
Authors: Sam McCrabb; Amanda L Baker; John Attia; Zsolt J Balogh; Natalie Lott; Kerrin Palazzi; Justine Naylor; Ian A Harris; Christopher M Doran; Johnson George; Luke Wolfenden; Eliza Skelton; Billie Bonevski Journal: BMC Psychiatry Date: 2019-01-17 Impact factor: 3.630